Congratulations Dr. Weber and the Island retina team for FDA approval of the Lucerne study - A new eye treatment called Vabysmo

Learn More

 

GRAYBUG VISION Logo

Regeneron

(Photon Study)

New Treatment for Diabetic Macular Edema

Enrollment is Closed

About this Study

A randomized, double-masked, active-controlled phase 2/3 study of the efficacy and safety of high-dose aflibercept in patients with diabetic macular edema.

This study is using a higher concentration of Eylea with the hope that patients will need injections much less frequently, hopefully, every 3-4 months and still maintain visual improvements.

Aerpio Logo

Genentech Lucerne Study

Enrollment is Closed

Congratulations Dr. Weber and the Island retina team for FDA approval of the Lucerne study - A new eye treatment called Vabysmo, this drug is approved for the treatment of wet AMD and Diabetic Macular Edema.

Alcon Logo

Opthea

(Coast Study)

New Treatment for Neovascular Age-Related Macular Degeneration

Enrollment is Open

About this Study

This is a phase 3 study looking at adding a new molecule in addition to Lucentis or Eylea. It is hoped that patients will have better results and less frequent treatment.

Treatment for Neovascular Age-Related Macular Degeneration

New Treatment for Neovascular Age-Related Macular Degeneration

Enrollment is Open

About this Study

This is a phase 2 study looking at a along-acting intraocular drug called vorolanib in patients previously treated for wet AMD.

It is hoped that this new drug will control the disease and reduce the need for frequent injections.

Genentech Logo

DRCR Retina Network

Fenofibrate for the treatment of diabetic retinopathy

Enrollment is Open

About this Study

This is a phase 3 study looking at a new oral treatment (pill) to prevent progression of diabetic eye disease and the need for laser and/or injections.

Genentech Logo

Oculis DX 219

New Treatment for diabetic macular edema using an eye drop

Enrollment is open

About this Study

Phase 2/3 study looking at an eye drop to treat diabetic macular edema.

For more detailed information about how Island Retina can help you see a brighter future, call us at one of our 2 convenient locations: Commack, NY 631-486-6672 or Shirley, NY 631-924-4300. You can also reach us by email through our website’s secure contact page.

Contact Us